GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 69 filers reported holding GW PHARMACEUTICALS PLC in Q1 2014. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $369,000 | +28.6% | 2,142 | +25.8% | 0.01% | +9.1% |
| Q1 2019 | $287,000 | -95.0% | 1,703 | -97.6% | 0.01% | -94.9% |
| Q3 2014 | $5,692,000 | +233.8% | 70,396 | +342.9% | 0.22% | +294.5% |
| Q2 2014 | $1,705,000 | -39.5% | 15,894 | -66.5% | 0.06% | -38.2% |
| Q1 2014 | $2,819,000 | – | 47,490 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |